Selling SARMs, Peptides, or Kratom? Why Processors Refuse You

On this page 8 sections

1. Card Network Rules on Unapproved Drugs and Banned Ingredients
2. Why a SARMs Payment Processor Is so Hard to Find
3. Peptides Payment Processing: Where the Line Falls
4. Kratom Merchant Accounts, Delta-8 Blends, and State-Level Bans
5. DMAA, Ephedra, and Other Prohibited Supplement Ingredients
6. How Transaction Laundering Gets Detected and Punished
7. Removing Risky SKUs to Qualify for a Mainstream Account
8. Next Steps

Key takeaways

• "High risk" means a processor can underwrite you with conditions. "Prohibited" means no compliant processor should approve you.
• "Research use only" labels do not override the marketing, dosing content, and customer intent signals that underwriters look for.
• Hiding banned SKUs behind a clean storefront is transaction laundering and can lead to termination, held funds, and MATCH listing.
• Removing prohibited products completely and documenting the rest is the realistic path to a stable nutraceutical merchant account.

If you've searched for a SARMs payment processor and found only declines, sudden account closures, or offers that sound too easy, there's a reason. Processors will underwrite some supplement-adjacent products as high risk, with reserves, monitoring, and extra paperwork. Card network rules and acquiring banks treat other products as prohibited. No label, disclaimer, or storefront design changes that.

This guide covers how underwriters tell the two apart, why "research use only" language doesn't protect a store, how hidden products get detected, and what to change if you want a mainstream account.

This article is general information, not legal or regulatory advice. Product legality depends on federal law, state law, and how a product is marketed, and it can change. Confirm your situation with a qualified attorney and with your processor.

Card Network Rules on Unapproved Drugs and Banned Ingredients

Card network rules generally bar acquiring banks from processing illegal transactions. The networks also restrict activity that could damage their brands. Acquirers pass those obligations to the processors and ISOs that board merchants, and those parties pass them to you through the merchant agreement.

For supplement sellers, three questions drive most decisions:

• Is the product lawful to sell to consumers in the places you ship it?
• Is it being sold as a drug without approval or a prescription? Products marketed to treat, cure, or prevent disease, or to act like a prescription drug, raise this issue.
• Has the ingredient been the subject of regulatory warnings or enforcement? Underwriters check, and you should too.

If any answer points the wrong way, the issue isn't your pricing tier. The product itself is the problem.

High Risk vs. Prohibited: The Distinction That Matters

The table below is a general guide to how underwriters tend to view common product categories. Each acquirer sets its own policies, so treat the table as a starting point, not a ruling.

Merchants in the high-risk categories can usually find a processor if they have the right documentation. To see how that works in practice, read our guide on how to get a nutraceutical merchant account approved and keep it live. Merchants in the prohibited categories can't, at least not compliantly.

Why a SARMs Payment Processor Is so Hard to Find

Selective androgen receptor modulators were developed as drug candidates, not as foods or dietary ingredients. When they're sold for human consumption, especially as bodybuilding or performance products, underwriters and acquiring banks generally treat them as unapproved drugs. Network rules and acquirer policies don't allow that category.

So the problem goes beyond high chargebacks or a tough MCC. A compliant acquirer won't knowingly process sales of a product it considers unlawful, whatever the reserve level. If you're unsure how your specific products are classified, confirm with a qualified regulatory attorney before you apply.

What "Research Use Only" Labels Actually Signal

Many SARMs and peptide stores print "for research use only, not for human consumption" on every page. Sellers assume this moves the product into a lawful lab-supply category. Underwriters don't read it that way. They look at the whole store and ask whether the claimed use is believable.

These signals tell an underwriter the "research" label is cosmetic:

• Dosing guides, cycle charts, or "stack" recommendations
• Bodybuilding, fat-loss, anti-aging, or performance imagery
• Before-and-after photos or customer reviews describing personal results
• Consumer-sized quantities, flavored liquids, or capsules
• Affiliate and influencer marketing on fitness social media
• No institutional purchasing, no buyer verification, and no B2B pricing
• Customer service scripts that answer "how should I take this?"

A genuine laboratory supplier usually sells to institutions, verifies its buyers, and keeps its content technical. A store aimed at gym-goers with a disclaimer in the footer is a consumer supplement store. Card brands, banks, and regulators judge it by its marketing, not its label.

Research Chemicals Credit Card Processing and Intent

The same logic applies to research chemicals credit card processing in general. Processors assess intent through the website, ad accounts, social channels, and dispute descriptions. When a cardholder files a chargeback saying the product "didn't help my workout," the dispute itself shows the product was bought for personal use.

Peptides Payment Processing: Where the Line Falls

Peptides sit closer to the middle of the spectrum than SARMs, which is why processors decide peptides payment processing applications case by case.

Some peptides are active ingredients in prescription drugs. Selling those compounds, or "research" versions of them, to consumers without a prescription looks like selling an unapproved or prescription drug. Other peptides appear in cosmetic, skincare, or protein products, which underwriters view very differently.

Underwriters typically want to see the following from a peptide seller:

• A clear product list that explains what each item is and how it's sold
• Certificates of analysis and supplier documentation
• No disease, injury, or weight-loss treatment claims
• No dosing or injection instructions aimed at consumers
• A licensed pharmacy and prescriber model if prescription products are involved. That is a separate business, closer to telehealth and online pharmacy payment processing than to supplements.

MannyPay works with peptide businesses; see the peptide merchant account page. As with any high-risk category, approval depends on underwriting.

Kratom Merchant Accounts, Delta-8 Blends, and State-Level Bans

SARMs are mainly a drug-classification problem. Kratom and hemp-derived cannabinoids are mainly a geography and documentation problem.

Kratom's legal status depends on both federal and state law. It varies from state to state, and some cities and counties set their own restrictions. Kratom also draws ongoing federal regulatory attention, so underwriters watch it closely. Delta-8 THC and similar hemp-derived intoxicants follow a patchwork of state rules that has changed often.

For a kratom merchant account, underwriters usually look for:

• Shipping controls that block orders to restricted states and localities
• Age verification where it's required, and as a general best practice everywhere
• Lab testing and clean labeling, with no therapeutic claims
• Product separation, so kratom isn't bundled with prohibited items such as unapproved "enhanced" extracts
• A clear refund policy and an accurate billing descriptor

Blends cause most of the trouble. A kratom or Delta-8 product combined with a flagged stimulant or an unapproved compound takes on the risk of its worst ingredient, so underwriters review the formula and not just the product name.

Related products such as 7-OH draw their own scrutiny. Our guide to getting approved for a 7-OH merchant account covers that category separately. MannyPay also serves kratom businesses; see the kratom payment processing page.

DMAA, Ephedra, and Other Prohibited Supplement Ingredients

Underwriters don't treat some prohibited supplement ingredients as gray areas.

• DMAA and related stimulants, which sometimes appear under other chemical names, are among the ingredients acquirers most commonly treat as off-limits in supplements.
• Ephedrine alkaloids (ephedra) carry a long regulatory and safety history in the supplement market, and processors widely restrict them.
• Undeclared drug ingredients are a separate red flag. Products marketed as supplements sometimes turn out to contain hidden prescription drug ingredients or analogs, most often in weight-loss, sexual-enhancement, and bodybuilding products.

Before listing any stimulant or performance ingredient, check the FDA's current public guidance and warnings, and confirm the ingredient's status with a regulatory attorney. Many processors compare a merchant's SKUs and ingredient lists against regulatory warnings during underwriting and again during ongoing monitoring.

An FDA warning letter naming your brand can trigger an immediate account review. Our article on what to do after an FDA warning letter for your supplement brand walks through that scenario.

Marketing can create a problem even when the ingredients are fine. Disease and drug-like claims are among the fastest ways to lose an account. See health claims that get supplement merchant accounts shut down.

How Transaction Laundering Gets Detected and Punished

Some merchants respond to a decline by running a "clean" vitamin store on one merchant account while quietly sending SARMs or DMAA sales through it. That's transaction laundering: processing sales for one business or product line under an account approved for something else. It breaks the merchant agreement and card network rules, and depending on the products, it may break the law.

It also gets caught more often than sellers expect. Common detection methods include:

• Web crawling and content monitoring that scans for products, keywords, and linked domains
• Test purchases made by acquirers or monitoring vendors
• Descriptor and order-data mismatches, such as ticket sizes, shipping origins, or product names that don't fit the approved business
• Chargeback and fraud reports in which cardholders describe what they actually bought
• Connected businesses and infrastructure, such as a shared checkout, owner, phone number, or fulfillment address tied to a known prohibited site

Legitimate multi-account setups exist, but every account must be fully disclosed and underwritten for what it actually sells. For the difference, see legal MID routing vs. transaction laundering.

What Happens After Detection

The consequences depend on the agreement and the acquirer. They can include:

1. Immediate termination of the merchant account
2. Held funds, with settlement money retained to cover chargebacks, refunds, and potential network assessments
3. Pass-through of fines that the acquirer receives from the card networks, if your contract allows it
4. MATCH listing, which flags the business and its principals to other acquirers and can make opening a new account elsewhere very difficult

A "research use only" disclaimer doesn't help here. Termination reviews look at what was sold and how it was presented, the same way underwriting does.

Removing Risky SKUs to Qualify for a Mainstream Account

If your catalog mixes ordinary supplements with prohibited items, the realistic path is to stop selling the prohibited products entirely. Hiding them or moving them elsewhere doesn't solve the problem. If your business is built mainly on SARMs or flagged ingredients, no compliant processor can board it, and you should plan around that.

Use this cleanup checklist:

1. Audit every SKU and ingredient, including blends and white-label products, against current FDA warnings and your processor's restricted list.
2. Delete prohibited products from every channel. Remove product pages, unlisted URLs, search results, sitemaps, cached pages, marketplace listings, and shopping feeds.
3. Stop selling prohibited products anywhere. That includes sister stores and other sites, whether or not they share infrastructure with your main store. Remove any links or redirects that point to them.
4. Rewrite your marketing to strip disease, drug-like, and dosing claims. Check ad accounts, affiliate pages, and influencer content too.
5. Gather documentation: supplier invoices, certificates of analysis, labels, and your refund and shipping policies.
6. Set geographic and age controls for state-restricted products such as kratom or hemp derivatives.
7. Disclose your full catalog on the application, including high-risk items you plan to keep.
8. Choose a straightforward billing model. Underwriters generally prefer straight sales over trial-to-subscription funnels.

Expect high-risk terms even after the cleanup, such as reserves, closer monitoring, and documentation requests. Our explainer on what a high-risk merchant account is and who needs one covers what those terms usually look like.

Next Steps

Start by sorting your catalog into high-risk and prohibited products. High-risk products can usually be underwritten with the right documentation, controls, and marketing. Prohibited products can't, and disguising them puts your account, your funds, and your future processing options at risk.

MannyPay works with high-risk and regulated businesses through its high-risk merchant accounts and nutraceutical payment processing. Approval always depends on underwriting. If you've cleaned up your catalog and want a review, request a free processing quote, and a MannyPay specialist will respond within one business day.

ME

About the author

MannyPay Editorial Team

Beyond the Swipe's editorial desk researches the publication's guides and news and cites its sources in every article. Articles reviewed by a named MannyPay editor carry that editor's byline.

This article is for general educational purposes and is not legal, tax or financial advice. Card network rules and state laws change; confirm current requirements for your business.